CATHERINE STEINKAMP: Open Payments
NPI 1073399614 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,383 in 89 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $674 · 2025 $2,383
Food & beverage: $2,383
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $973 |
| Janssen Biotech, Inc. | 11 | $493 |
| UCB, Inc. | 11 | $181 |
| Amgen Inc. | 5 | $150 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| SANOFI-AVENTIS U.S. LLC | 2 | $70 |
| Tandem Diabetes Care, Inc. | 4 | $62 |
| Almatica Pharma LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $37 |
Products named: RINVOQ, TREMFYA, SKYRIZI, Bimzelx, EVENITY, COSENTYX, ORENCIA, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across KY — which companies pay providers there.
